Literature DB >> 8049026

Incidence of autoimmune antibodies in failed embryo transfer cycles.

A Birkenfeld1, T Mukaida, L Minichiello, M Jackson, N G Kase, M Yemini.   

Abstract

PROBLEM: The presence of antiphospholipid antibodies lupus anticoagulant (LAC), anticardiolipin antibody (ACA) as well as antinuclear antibody (ANA) has been associated with early spontaneous pregnancy loss and adverse pregnancy outcome. The purpose of this study was to investigate the possible role of autoimmune antibodies (LAC, ACA, and ANA) as a cause of implantation failure following embryo transfer (ET) after in vitro fertilization (IVF).
METHOD: Three groups were studied: Group I, 56 patients who failed to conceive following ET; group II, 14 patients who have conceived following IVF-ET and delivered or are carrying an uncomplicated ongoing pregnancy; and group III, 69 patients who were new candidates for IVF-ET.
RESULTS: Eighteen out of 56 (32.1%) of patients who failed to conceive following previous IVF-ET cycle (group I) tested positive for one or more of the autoimmune antibodies. None of the 14 patients of group II tested positive for autoimmune antibodies (P < .02). Seven out of the 69 patients (10%) of group III were found positive to one or more of the autoimmune factor. This rate is significantly lower than the rate of positive autoimmune antibodies detected in group I (P < .003). Fifteen patients of the 18 who tested positive for autoimmune antibodies and who had previously failed to conceive following ET underwent a subsequent IVF-ET cycle while being treated with prednisone and aspirin. Seven out of the 15 (46.6%) conceived and were able to sustain a clinical ongoing pregnancy.
CONCLUSIONS: Patients receiving ET are carrying viable embryos within the intrauterine environment. Therefore, in this unique group of patients, failure to demonstrate a positive pregnancy test represents an implantation failure or a very early postimplantation loss. The results of this study suggest that periimplantation events may be affected by autoimmune antibodies. Very early miscarriage or implantation failure may be related to the same pathophysiological mechanism that causes recurrent miscarriages and is diagnosed incorrectly as infertility.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049026     DOI: 10.1111/j.1600-0897.1994.tb00848.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  5 in total

Review 1.  Low molecular weight heparin in immunological recurrent abortion--the incredible cure.

Authors:  Gautam N Allahbadia; Swati G Allahbadia
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

Review 2.  Anticoagulant therapy and pregnancy.

Authors:  Aiko Makino; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2008-02-01

3.  Antiphospholipid antibodies associated with implantation failure after IVF/ET.

Authors:  C B Coulam; B D Kaider; A S Kaider; P Janowicz; R G Roussev
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

Review 4.  Female Infertility and Serum Auto-antibodies: a Systematic Review.

Authors:  Alban Deroux; Chantal Dumestre-Perard; Camille Dunand-Faure; Laurence Bouillet; Pascale Hoffmann
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

5.  Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.

Authors:  Eirini Papadimitriou; Georgios Boutzios; Alexander G Mathioudakis; Nikos F Vlahos; Panayiotis Vlachoyiannopoulos; George Mastorakos
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.